ID2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.527700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.991800E-01
Normal-vs-Stage2
1.698410E-02
Normal-vs-Stage3
4.448000E-02
Normal-vs-Stage4
2.588400E-01
Stage1-vs-Stage2
3.549800E-01
Stage1-vs-Stage3
1.430380E-01
Stage1-vs-Stage4
5.951800E-01
Stage2-vs-Stage3
2.654000E-01
Stage2-vs-Stage4
7.079400E-01
Stage3-vs-Stage4
2.437200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.720400E-02
Normal-vs-AfricanAmerican
3.411600E-01
Normal-vs-Asian
7.942000E-02
Caucasian-vs-AfricanAmerican
1.762370E-01
Caucasian-vs-Asian
7.156600E-01
AfricanAmerican-vs-Asian
2.784800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.199680E-02
Normal-vs-Female
9.649800E-02
Male-vs-Female
1.905570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.544800E-01
Normal-vs-Age(41-60Yrs)
4.697900E-02
Normal-vs-Age(61-80Yrs)
3.524200E-02
Normal-vs-Age(81-100Yrs)
1.366600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.670600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.497600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.706200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.633800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.881000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.499800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.246000E-02
Normal-vs-Daily Drinker
2.817200E-03
Normal-vs-Weekly Drinker
6.698000E-03
Normal-vs-Occasional Drinker
2.470000E-01
Normal-vs-Social Drinker
7.526000E-02
Non Drinker-vs-Daily Drinker
1.397800E-01
Non Drinker-vs-Weekly Drinker
4.392000E-01
Non Drinker-vs-Occasional Drinker
8.277800E-01
Non Drinker-vs-Social Drinker
6.871000E-01
Daily Drinker-vs-Weekly Drinker
5.352800E-01
Daily Drinker-vs-Occasional Drinker
2.720000E-01
Daily Drinker-vs-Social Drinker
7.650100E-02
Weekly Drinker-vs-Occasional Drinker
4.574000E-01
Weekly Drinker-vs-Social Drinker
2.471400E-01
Occasional Drinker-vs-Social Drinker
9.480600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.545170E-01
Normal-vs-Grade 2
2.782300E-02
Normal-vs-Grade 3
4.304300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.979200E-01
Grade 1-vs-Grade 3
8.508200E-01
Grade 1-vs-Grade 4
1.545170E-01
Grade 2-vs-Grade 3
2.293200E-01
Grade 2-vs-Grade 4
2.782300E-02
Grade 3-vs-Grade 4
4.304300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.077550E-02
Normal-vs-NonDiabetic
3.169800E-02
Diabetic-vs-NonDiabetic
3.756000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.531600E-02
Normal-vs-NoPancreatitis
2.180000E-02
Pancreatitis-vs-NoPancreatitis
6.635600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.441380E-01
Normal-vs-N1
1.266070E-02
N0-vs-N1
8.426200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.562300E-02
Normal-vs-TP53-NonMutant
1.465990E-01
TP53-Mutant-vs-TP53-NonMutant
1.932190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
